Skip to main content

Advertisement

SpringerLink
Log in

CNS demyelination associated with nilotinib

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Kumar N, Abboud H (2019) Iatrogenic CNS demyelination in the era of modern biologics. Mult Scler 25(8):1079–1085

    Article  PubMed  Google Scholar 

  2. Rekhi E, Pryce A, Sohal M et al (2016) CNS demyelination in patients on nilotinib treatment for CML. J Neurol Neurosurg Psychiatry 87(12):e1

    Article  Google Scholar 

  3. Rimkus CM, Schoeps VA, Boaventura M et al (2021) Drug-related demyelinating syndromes: understanding risk factors, pathophysiological mechanisms and magnetic resonance imaging findings. Mult Scler Relat Disord 55:103146

    Article  CAS  PubMed  Google Scholar 

  4. Judge C, Moheb N, Melinosky C (2019) Nilotinib-associated demyelinating disease: case report. Neurol 92(Supplement1):P.22-093

    Google Scholar 

  5. Liu Y, Wang Z et al (2011) Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib. J Hepatol 55:612–625

    Article  CAS  PubMed  Google Scholar 

  6. Betsholtz C (2004) Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev 15(4):215–228

    Article  CAS  PubMed  Google Scholar 

  7. Wilson H, Scolding N, Raine C (2006) Co-expression of PDGF a receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. J Neuroimmunol 176:162–173

    Article  CAS  PubMed  Google Scholar 

  8. Zeitelhofer M, Adzemovic M et al (2020) Blocking PDGF- CC signaling ameliorates multiple sclerosis- like neuroinflammation by inhibiting disruption of the blood–brain barrier. Sci Rep 10(1):22383

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Nachliely M, Trachtenberg A et al (2019) Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model. J Steroid Biochem Mol Biol 188:8–16

    Article  CAS  PubMed  Google Scholar 

  10. Xu JG, Cheng Q et al (2022) Effect of dimethyl fumarate (DMF) on T-cell acute lymphoblastic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 30(1):1–5

  11. Maeta T, Sato T et al (2022) Dimethyl fumarate induces apoptosis via inhibiting NF-κB and STAT3 signaling in adult T-cell leukemia/lymphoma cells. Anticancer res 42(5):2301–2309

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Gazi University School of Medicine, Ankara, Turkey

    Ezgi Erturul, Belgin Kocer & Saliha Gokce

  2. Department of Radiology, Gazi University School of Medicine, Ankara, Turkey

    Murat Ucar

Authors
  1. Ezgi Erturul
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Belgin Kocer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Saliha Gokce
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Murat Ucar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ezgi Erturul.

Ethics declarations

Ethics approval

This paper was approved by the Ethical committee from the blinded manuscript.

Informed consent

Informed consent was received from patient.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Erturul, E., Kocer, B., Gokce, S. et al. CNS demyelination associated with nilotinib. Neurol Sci 44, 3335–3339 (2023). https://doi.org/10.1007/s10072-023-06827-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-06827-4

Search

Navigation